Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers
Clinical trial NCT05125575 · COMPLETED
Trial details
- NCT number
- NCT05125575
- Sponsor
- Joint Stock Company "Farmak"
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-11
- Primary completion
- 2019-01-19
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.